Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Correction: slanDCs/M-DC8+ cells constitute a distinct subset of dendritic cells in human tonsils.

Micheletti A, Finotti G, Calzetti F, Lonardi S, Zoratti E, Bugatti M, Stefini S, Vermi W, Cassatella MA.

Oncotarget. 2016 Oct 4;7(40):66323. doi: 10.18632/oncotarget.12418. No abstract available.

2.

slanDCs/M-DC8+ cells constitute a distinct subset of dendritic cells in human tonsils [corrected].

Micheletti A, Finotti G, Calzetti F, Lonardi S, Zoratti E, Bugatti M, Stefini S, Vermi W, Cassatella MA.

Oncotarget. 2016 Jan 5;7(1):161-75. doi: 10.18632/oncotarget.6660. Erratum in: Oncotarget. 2016 Oct 4;7(40):66323.

3.

M-DC8+ leukocytes--a novel human dendritic cell population.

Schäkel K, Poppe C, Mayer E, Federle C, Riethmüller G, Rieber EP.

Pathobiology. 1999;67(5-6):287-90.

PMID:
10725804
4.

Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant.

Mimiola E, Marini O, Perbellini O, Micheletti A, Vermi W, Lonardi S, Costantini C, Meneghelli E, Andreini A, Bonetto C, Vassanelli A, Cantini M, Zoratti E, Massi D, Zamo' A, Leso A, Quaresmini G, Benedetti F, Pizzolo G, Cassatella MA, Tecchio C.

Clin Exp Immunol. 2014 Oct;178(1):129-41. doi: 10.1111/cei.12387.

5.

Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.

Günther C, Blau K, Förster U, Viehweg A, Wozel G, Schäkel K.

Exp Dermatol. 2013 Aug;22(8):535-40. doi: 10.1111/exd.12190.

PMID:
23879812
6.

Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation.

Mager K, Wehner R, Bahr F, Oelschlägel U, Platzbecker U, Wermke M, Shayegi N, Middeke JM, Radke J, Röllig C, Schetelig J, Thiede C, Ehninger G, Schmitz M, Bornhäuser M, Tuve S.

Transplantation. 2012 Jun 27;93(12):1270-5. doi: 10.1097/TP.0b013e31824fd8b4.

PMID:
22643330
7.

Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus.

Hänsel A, Günther C, Baran W, Bidier M, Lorenz HM, Schmitz M, Bachmann M, Döbel T, Enk AH, Schäkel K.

J Autoimmun. 2013 Feb;40:1-8. doi: 10.1016/j.jaut.2012.07.005. Epub 2012 Aug 11.

PMID:
22890025
8.

The M-DC8-positive leukocytes are a subpopulation of the CD14+ CD16+ monocytes.

Siedlar M, Frankenberger M, Ziegler-Heitbrock LH, Belge KU.

Immunobiology. 2000 May;202(1):11-7.

PMID:
10879684
9.

A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs).

Bippes CC, Feldmann A, Stamova S, Cartellieri M, Schwarzer A, Wehner R, Schmitz M, Rieber EP, Zhao S, Schäkel K, Temme A, Scofield RH, Kurien BT, Bartsch H, Bachmann M.

PLoS One. 2011 Jan 21;6(1):e16315. doi: 10.1371/journal.pone.0016315.

10.

slanDCs selectively accumulate in carcinoma-draining lymph nodes and marginate metastatic cells.

Vermi W, Micheletti A, Lonardi S, Costantini C, Calzetti F, Nascimbeni R, Bugatti M, Codazzi M, Pinter PC, Schäkel K, Tamassia N, Cassatella MA.

Nat Commun. 2014;5:3029. doi: 10.1038/ncomms4029.

PMID:
24398631
11.

The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.

Oehrl S, Prakash H, Ebling A, Trenkler N, Wölbing P, Kunze A, Döbel T, Schmitz M, Enk A, Schäkel K.

J Dermatol Sci. 2017 Aug;87(2):110-115. doi: 10.1016/j.jdermsci.2017.04.005. Epub 2017 Apr 20.

PMID:
28499587
12.

Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.

Oehrl S, Olaru F, Kunze A, Maas M, Pezer S, Schmitz M, Schäkel K.

J Dermatol Sci. 2017 Sep;87(3):278-284. doi: 10.1016/j.jdermsci.2017.06.016. Epub 2017 Jun 24.

PMID:
28732748
13.

Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells.

Wehner R, Löbel B, Bornhäuser M, Schäkel K, Cartellieri M, Bachmann M, Rieber EP, Schmitz M.

Int J Cancer. 2009 Jan 15;124(2):358-66. doi: 10.1002/ijc.23962.

14.

Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.

Thomas K, Dietze K, Wehner R, Metz I, Tumani H, Schultheiß T, Günther C, Schäkel K, Reichmann H, Brück W, Schmitz M, Ziemssen T.

Neurol Neuroimmunol Neuroinflamm. 2014 Sep 18;1(3):e33. doi: 10.1212/NXI.0000000000000033. eCollection 2014 Oct.

15.

Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis.

Toma M, Wehner R, Kloß A, Hübner L, Fodelianaki G, Erdmann K, Füssel S, Zastrow S, Meinhardt M, Seliger B, Brech D, Noessner E, Tonn T, Schäkel K, Bornhäuser M, Bachmann MP, Wirth MP, Baretton G, Schmitz M.

Oncoimmunology. 2015 Mar 2;4(6):e1008342. eCollection 2015 Jun.

16.

Pivotal role of M-DC8⁺ monocytes from viremic HIV-infected patients in TNFα overproduction in response to microbial products.

Dutertre CA, Amraoui S, DeRosa A, Jourdain JP, Vimeux L, Goguet M, Degrelle S, Feuillet V, Liovat AS, Müller-Trutwin M, Decroix N, Deveau C, Meyer L, Goujard C, Loulergue P, Launay O, Richard Y, Hosmalin A.

Blood. 2012 Sep 13;120(11):2259-68. doi: 10.1182/blood-2012-03-418681. Epub 2012 Jul 16.

17.

TNFR2 and IL-12 coactivation enables slanDCs to support NK-cell function via membrane-bound TNF-α.

Tufa DM, Chatterjee D, Low HZ, Schmidt RE, Jacobs R.

Eur J Immunol. 2014 Dec;44(12):3717-28. doi: 10.1002/eji.201444676. Epub 2014 Oct 29.

18.

slanDCs in carcinoma-draining lymph nodes.

Vermi W, Lonardi S, Bugatti M, Calzetti F, Micheletti A, Cassatella MA.

Oncoimmunology. 2014 Jan 1;3(3):e28246. Epub 2014 Mar 17.

19.

FcγRIII (CD16) equips immature 6-sulfo LacNAc-expressing dendritic cells (slanDCs) with a unique capacity to handle IgG-complexed antigens.

Döbel T, Kunze A, Babatz J, Tränkner K, Ludwig A, Schmitz M, Enk A, Schäkel K.

Blood. 2013 May 2;121(18):3609-18. doi: 10.1182/blood-2012-08-447045. Epub 2013 Mar 4.

20.

[The role of human 6-sulfo LacNAc dendritic cells (slanDCs) in autoimmunity and tumor diseases].

Döbel T, Schäkel K.

J Dtsch Dermatol Ges. 2014 Oct;12(10):874-80. doi: 10.1111/ddg.12439_suppl. Review. German.

PMID:
25262889

Supplemental Content

Support Center